Cancer and the Immune System: Deciphering the Relationship
Type
Blog Post
...molecular targets under research include TIM-3, LAG-3, STAT-3, EGFR, CD20 and CD73 on specific solid as ...cell-surface antigen production to evade the immune system.
3. Escape - Tumor cells that survive this phase are ... situ before being injected back into the body in 3 doses intravenously. B cells and T cells activated...medicine 10.9 (2004): 942-949. PubMed PMID: 15322536.
3. Dunn, Gavin P., et al. "Cancer immunoediting: from...potential beneficiaries.
Collaborative therapy
For the most efficient outcomes, collaborative therapies must be... of the tolerance-producing antigens enunciated above. Finally, signals released from the microenvironment...are in their clinical trial phase.
In all of the above therapeutics, techniques like genome engineering...